The U.S. missionary who tested positive for Ebola has been given drugs aimed at reducing disease symptoms after exposure to the virus and other therapies, U.S. health officials said. May 22, 2026 ...

The partnership will combine OpenBench’s discovery platform with Concept Life Sciences’ expertise in medicinal chemistry.

3 Blue-Chip Stocks Built for a Rotating Market Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

Sydney's life sciences sector has reached a major milestone, with Kurraba Group announcing the first confirmed partners for ION – a purpose-built commercial life sciences precinct set to redefine ...

Gilead Sciences Inc. (NASDAQ:GILD) is one of the cheap NASDAQ stocks to buy right now. On May 21, Gilead Sciences completed ...

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...

To help fill the ever-growing need for new health care workers, St. Luke’s University Health Network has just opened its own ...

A Laredo College summer camp is giving middle and high school students hands-on experience exploring careers in the ...